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A 5-year-old girl is admitted to the paediatric intensive care unit
with meningococcal sepsis. She is hypotensive and requires
fluid resuscitation. You are trying to decide which type of fluid
to choose (crystalloids or natural colloids [albumin]).
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Abstract
Despite decades of resuscitating patients with intravenous fluids in intensive care units, it is somewhat
surprising that very little consensus exists regarding the type of fluid physicians should choose. Factors
that influence decisions are often local culture or politics, hospital administrators, history (i.e. ‘I’ve
always done it this way’) and budgets, as opposed to strong evidence. In the present issue of Critical
Care we are presented with compelling arguments for and against the administration of colloids (as
opposed to crystalloids) in paediatric sepsis. One point that appears to be clear is that the ideal choice
of intravenous fluid goes beyond the simple haemodynamic effect. As such, in the future, clinicians will
need to consider other factors when making their decision. In addition, large-scale quality randomised
studies are desperately needed to guide clinicians.
Keywords crystalloids, colloids, sepsis
The scenario
Pro: Yes, colloids have advantages over crystalloids in paediatric sepsis
Puran Khandelwal and Desmond Bohn
Meningococcal sepsis is a fulminant form of Gram-negative
sepsis associated with profound shock. The release of
endotoxins (lipopolysaccharides) from the bacterial cell wall
initiates a cascade of events resulting in the release of
cytokines (IL-1, IL-6, tumour necrosis factor alpha), which in
turn causes endothelial cell injury with capillary leak and loss
of vasomotor tone [1].
Plasma proteins, including albumin, and water from the
intravascular compartment leak into the interstitium, resulting
in hypovolaemia and hypotension [2]. Fleck and colleagues
[3] showed that there is an increase of 300% in the albumin
escape rate from the vascular to the interstitial space,
associated with hypoalbuminaemia, in septic patients.
Hypoalbuminaemia is also associated with increased
mortality in critically ill patients [4].
Holland and colleagues [5]found albumin fragments of
approximately 45 kDa, 25 kDa, and <20 kDa in the urine of
children with meningococcal sepsis and associated purpura.
They suggested that exogenous or endogenous proteases,
or both, may be released in severe meningococcal sepsis
and, in association with an inadequate antiprotease
response, result in albumin degradation. This may be a
contributory factor to the rapid shock, hypocalcaemia, and
rash seen in meningococcal sepsis.Available online http://ccforum.com/content/6/4/286
Early fluid resuscitation in paediatric septic shock improves
outcome [6], but there is ongoing controversy over the type of
fluid to be used [7–10]. Two published meta-analyses, by the
Cochrane group, of randomised trials that compared
crystalloids with colloids or crystalloids with albumin attracted
considerable attention [8,10]. They concluded that the use of
both colloids was associated with increased mortality in
critically ill patients. Most of the trials were small studies that
were insufficiently powered to address mortality. There were
only six paediatric studies analysed, five of which were in
neonates, one was in burns in children. None were in patients
with sepsis. Despite the concerns raised by the publication of
these papers, early aggressive fluid resuscitation with albumin,
specialist advice and transfer to a paediatric intensive care unit
for patients with meningococcal sepsis in the UK has reduced
mortality from 50% in severely ill patients to less than 5% [11].
Understanding of the distribution of colloids and crystalloids
in the different fluid compartments is fundamental to fluid
resuscitation. Ernest and colleagues [12]studied the
distribution of normal saline and 5% albumin in septic
patients. Normal saline increases the extracellular fluid
compartment 1:1 ratio with only 20% remaining with the
intravascular space, whereas 5% albumin increases
extracellular fluid more than twice and is distributed equally
intravascularly and interstitially. Volume for volume, two to
three times as much crystalloid needs to be used as colloid
for the same haemodynamic effect.
Dengue shock syndrome has a similar pathophysiology of
increased capillary leak to meningococcal sepsis. A recent
randomised, controlled trial showed greater improvements in
haematocrit, pulse pressure, and cardiac index among children
with Dengue shock syndrome who received colloid compared
with a crystalloid [13]. Metabolic acidosis with high lactate is a
common finding during presentation of these children. The use
of a large volume of and rapid infusion of normal saline will
produce hyperchloraemic acidosis and has the potential to
worsen acidosis [14,15]. This dilutional acidosis may impair
myocardial function and make inotropes less effective.
Con: No, colloids do not have advantages over crystalloids in paediatric sepsis
Joseph A Carcillo and Neal J Thomas
It is well accepted that fluid resuscitation in paediatric septic
shock is critical. Carcillo and colleagues [6] reported a
decade ago that paediatric patients in septic shock had
reduced mortality with rapid fluid administration, initially with
crystalloids but with one-third of the total fluid given as
colloid. The advantages of vigorous fluid resuscitation have
also been demonstrated in septic animals [16]. However, the
debate continues concerning the optimum initial fluid to
utilise. After reviewing the available literature concerning
primary fluid options, we present facts that refute the
statement ‘colloids have advantages over crystalloids in
paediatric sepsis’.
To defend the statement that colloids are superior, one must
prove their benefit in the clinical setting described: paediatric
septic shock. Because of the lack of literature available in this
patient subset, a broad base of literature review must cover
adult patients in a wide variety of clinical situations, including
sepsis. Multiple systemic reviews have been published
recently. Choi and colleagues [7] reviewed 17 studies
encompassing 814 patients that compared isotonic
crystalloids with colloids for fluid resuscitation. The authors
concluded that there was no advantage in terms of outcome or
length of stay with colloids. In an attempt to determine whether
a larger amount of colloid or crystalloid remained in the
intravascular compartment, Ernest and colleagues [12]
randomised septic adult patients to receive either normal saline
or 5% albumin. They concluded that there was no advantage in
the haemodynamics of patients who received albumin.
To further this argument, we present the case that colloids
may actually be harmful to patients. Castro and colleagues
[17] raised concerns about the adverse rheologic effects with
colloid infusions, citing that hydroxyethyl starch increases
blood viscosity and has the potential to impair microvascular
flow during sepsis. Additionally, a recent meta-analysis of 30
randomised, controlled trials including 1149 patients
concluded that, in addition to no evidence suggesting that
mortality was improved with albumin administration, there was
a strong suggestion that albumin may actually increase
mortality [10]. Another meta-analysis [8] revealed an
increased absolute risk of mortality of 4% in patients
resuscitated with colloids. These studies have prompted the
Food and Drug Administration to issue a warning: “… the
FDA urges treating physicians to exercise discretion in use of
albumin …” (http://www.fda.gov/cber/ltr/albumin.htm).
In this age of cost containment, attention must also be
paid to the utilisation of health care dollars. The cost of
initially administering colloid solutions can be tremendous.
Crystalloid solutions can generally be acquired at
$1/500 ml, in comparison with hydroxyethyl starch
($45/500 ml) or 5% albumin ($76/100 ml) [18]. It is easy
to see that the utilisation of crystalloid solutions for initial
resuscitative measures can result in significant cost
savings.
Based on the lack of evidence documenting improved
outcome, potential deleterious effects, and substantial
economic strain on the health care system, we agree with the
recent review by Alderson and colleagues [19]. They
concluded “it is hard to see how their (colloids) continued
use in these patient types (critically ill) can be justified
outside the context of randomized controlled trials”.Critical Care    August 2002 Vol 6 No 4 Khandelwal et al.
Pro’s response
Puran Khandelwal and Desmond Bohn
Carcillo and Thomas noted that colloid was used when
crystalloids failed to improve perfusion or blood pressure, or for
correcting coagulation. Ernest and colleagues [12] used 5%
albumin or normal saline to achieve a similar haemodynamic
target (pulmonary artery occlusion pressure = 15 mmHg), and
found albumin more efficient (122% versus 21%).
Meta-analyses are limited in their ability to examine the
effects of crystalloids or colloids for fluid resuscitation. The
heterogeneity in the study population, selection criteria and
different outcome measures included in the meta-analysis
can influence the result. It is interesting to note, however, that
Wilkes and Navickis [9] have shown in their meta-analysis
that albumin has no effect on mortality.
An appropriately powered and clinically relevant randomised,
controlled clinical trial is needed to resolve these issues.
Con’s response
Joseph A Carcillo and Neal J Thomas
Khandelwal and Bohn present some excellent arguments to
support their view that colloids should be administered as
resuscitative fluids in this child. However, the prime question
concerning whether colloids will improve outcome in this
type of patient remains unanswered.
We agree that the literature is limited with regards to
paediatric septic shock, but this should not cause us to
ignore the data that has been generated by our adult
colleagues and to recommend a therapy that may in fact be
harmful. Instead, it should invite us to answer the question in
our distinct population of children with septic shock by a
well-planned, randomised, controlled trial.
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